Learn complex topic fast under deadline

Behavioral Prompt: Rapid Ramp-Up on a New Analytical Framework

You had to learn a new analytical framework in under a week to deliver a high-stakes review.

Provide:

1. A real example (brief context, stakes, and the framework you adopted).
2. Your day-by-day learning and execution plan.
3. The minimum viable artifacts you produced (docs, code, analyses).
4. How you validated correctness under time pressure.
5. The trade-offs you made and why.
6. Objective signals that your ramp-up worked or failed.
7. How you would adjust the plan if the deadline moved up by 48 hours.

Solution

Example Context

Scope: A high-stakes product review needed a causal estimate of a policy change on DAU and 7‑day retention. A randomised experiment had been aborted due to an infrastructure issue, so I needed a credible observational method within a week.

New framework: Bayesian Structural Time Series (BSTS) via the CausalImpact approach to construct a counterfactual from control series and estimate treatment effect with uncertainty.

Stakeholders: Product, Eng, Data Science, and an executive sponsor expecting a go/no-go decision for full rollout.

Assumptions (made explicit up front):

• Pre-period is long enough to learn seasonality/trends (≥90 days).
• Covariates are predictive and not affected by treatment (no leakage).
• The post-period is short (≈2 weeks), so uncertainty will be non-trivial.

Plan by Day (5 working days)

Day 1 — Problem framing and feasibility

• Clarify decision question, KPIs, and acceptable uncertainty (e.g., “OK if 95% interval width ≤2pp”).
• Inventory data: outcome series, candidate control series (peer geos, older cohorts), known events (holidays, outages).
• Skim core materials: CausalImpact vignettes, BSTS model structure (local level/trend, seasonality, spike-and-slab regression), leakage pitfalls.
• Define MVE (minimum viable estimate): one primary KPI (DAU), one secondary (7‑day retention), a single model variant, and at least two high-ROI validation checks.

Day 2 — First working prototype

• Build a reproducible notebook using a well-tested library (R CausalImpact or Python causal_impact equivalent).
• Preprocess: align calendars, remove outlier days, z-score covariates, hold back a validation window.
• Fit baseline model with 120-day pre-period and 14-day post-period; include weekday seasonality and 5–10 control series.
• Produce first cut: point estimate, 95% posterior intervals, and time-series plots.

Day 3 — Validation and leakage control

• Placebo tests: rotate “treated” label across comparable geos or time windows; ensure the observed effect is in the extreme tail of placebo distribution.
• Backtesting: rolling-origin forecasts entirely within pre-period; compute RMSPE and calibration of posterior intervals.
• Sensitivity: remove top predictors; vary pre-period length; check prior sensitivity for state components.
• Quick triangulation with a simpler method (two-way fixed-effects DiD with geo and calendar FE) to see if effect direction and magnitude roughly agree.

Day 4 — Harden and communicate

• Lock covariate set after leakage checks (exclude any series that moved post-treatment).
• Document assumptions, diagnostics (RMSPE, coverage), and sensitivity grids.
• Create decision-ready artifacts: 1-page exec summary, appendix slides with diagnostics, and a reproducible notebook.
• Peer review: 30-minute DS peer pass for sanity and failure-mode audit.

Day 5 — Final review and contingency

• Dry run with PM/Eng to align on interpretation and caveats.
• Precompute alternative slices (by platform or region) only if they meet minimum sample thresholds.
• Prepare contingency slide with trade-offs if asked to expand/contract scope.

Minimum Viable Artifacts (produced)

• 1-page decision memo: question, method, headline effect, uncertainty, assumptions, and recommended decision.
• Reproducible notebook: data prep, model fit, diagnostics, and plots (seeded for determinism).
• Data dictionary: sources, transformations, and filters.
• Validation checklist: placebo/backtest results, sensitivity table, leakage checks.
• 5–7 slide deck for execs; appendix with methodology.

Validation Under Time Pressure

• Pre-period fit quality: RMSPE and posterior predictive checks. Target RMSPE <3% for DAU; <5% for retention.
• Placebo tests: Effect percentile vs. 50+ placebo geos/windows; empirical p-value.
• Backtests: Rolling-origin 7-day forecasts; coverage of 95% intervals >90%.
• Triangulation: Compare with DiD (two-way FE). Directional agreement and overlapping intervals are a positive signal.
• Leakage checks: Remove any covariate with significant post-period shift correlated with treatment.

Illustrative results (numbers from the actual run):

• Pre-period RMSPE (DAU): 2.1%; coverage in backtests: 92%.
• Estimated DAU lift: +1.8% [0.5%, 3.0%] over 14 days; retention: +0.4pp [0.1pp, 0.7pp].
• Placebo distribution: observed effect at 97th percentile (empirical p≈0.03).
• DiD estimate: +1.6% [0.2%, 3.1%] — intervals overlap and direction matches.

Trade-offs Made

• Chose a well-documented off-the-shelf BSTS over a custom model to save time; accepted limited hyperparameter exploration.
• Restricted to one primary KPI and one secondary to keep validation focused.
• Curated 8 high-signal control series to reduce computation and overfitting risk; did not pursue automated feature search beyond spike-and-slab.
• Short post-period (14 days) increased uncertainty; accepted wider intervals with stronger placebo evidence.

Objective Signals of Success/Failure

Success signals observed:

• Quantitative: low RMSPE, good coverage, strong placebo separation, triangulation agreement.
• Process: peer review passed with only minor comments; reproducibility confirmed by reruns (same seed → same summary stats).
• Outcome: Executive accepted recommendation; subsequent staged geo A/B (two weeks later) yielded +1.5% [0.4%, 2.6%], within our credible interval.

Potential failure signals to watch:

• High pre-period error or poor coverage; effect not distinguishable from placebo distribution; large swings under small modeling changes; covariate leakage detected.

How I’d Update If Deadline Moved Up by 48 Hours

Time compression strategy (focus on decision usefulness, not exhaustiveness):

• Scope cut: Only DAU, single geo-grouping, and a single model variant.
• Method simplification: Start with two-way FE DiD (geo and calendar FE, robust SEs). Use BSTS only if DiD diagnostics pass quickly and time permits.
• Validation triage: Keep the two highest-ROI checks — placebo over time windows and pre-period backtest; drop extended sensitivity grid.
• Covariate discipline: Use a pre-vetted set of controls (historically predictive, known non-reactive) to avoid leakage work.
• Communication: Deliver a 1-page decision with clear caveats and a risk register; propose a follow-up validation plan post-decision.

Compressed 3-day plan:

• Day 1: Frame question, assemble data, run DiD baseline with diagnostics; produce early read.
• Day 2: Run minimal BSTS with vetted controls; quick placebo and backtest; reconcile with DiD.
• Day 3: Finalize memo and slides; peer spot-check; deliver.

Guardrails in the compressed plan:

• Precommit to thresholds (e.g., require placebo p<0.1 and backtest coverage >85%); if not met, escalate uncertainty and recommend staged rollout rather than full launch.

Pitfalls and How I Avoided Them

• Covariate leakage: excluded any series showing contemporaneous jumps post-policy; preference for upstream, non-treated signals.
• Seasonality and holidays: included weekday factors and explicit holiday dummies.
• Data quality: monitored missingness/outliers; winsorized extreme days with documented rationale.
• Over-interpretation: reported point estimates with credible intervals and emphasized decision thresholds, not single-number precision.